论文部分内容阅读
Lim Jung—bin领导的国立汉城大学遗传学实验室首次在韩国成功地研制出一种被称为“传送媒介”(vector)的物质,这种物质的发现,使得用基因方法来治疗像癌症或艾滋病这样一些疾病的愿望有可能成为现实。该实验室已经与英国牛津大学生物医学部门签署了一项价值7万美元的技术转让合同。 这种新的方法不同于现行的采用化学或生物物质的各种基因治疗方法,它是抽出人体细胞并把抗病毒基因注射进去,然后再把这些注射了抗病毒基因的细胞注入人体内,这样就能使人体进行自疗。从前,由于在把抗病毒基因注射进人体方面存在着困难,因此基因治疗法一直未得到广泛采用。但是“传送媒介”的开发标志着这一领域取得了重要转折。
For the first time in Korea, a genetics lab led by Lim Jung-bin led by Seoul National University successfully developed a substance called “vector” that has led to the discovery that genetic approaches to the treatment of cancer-like or The aspirations of some diseases such as AIDS are likely to become a reality. The lab has signed a $ 70,000 technology transfer contract with the biomedical unit of the University of Oxford in the UK. This new method is different from the current use of chemical or biological substances in a variety of gene therapy, it is extracted from human cells and the injection of anti-viral genes, and then these injected with anti-viral genes into the human body cells, so Can make the body self-treatment. In the past, gene therapy has not been widely adopted because of difficulties in injecting the antiviral gene into the human body. However, the development of “transmission media” marks a major turning point in this area.